Navigation Links
Comorbidities should be factor in prostate biopsy choice, UCI study finds
Date:5/15/2013

UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-Cap) and the physician-reported Charlson Comorbidity Index can successfully target prostate patients who would not benefit from biopsy to discover possible cancer.

The authors say that by taking comorbidities into factor, it may not be necessary for men to have prostate biopsy. This study does not preclude the use of PSA screening, but it does set the stage for a new and much more targeted strategy for biopsy choice. The desired result fewer unneeded biopsies and fewer invasive, side-effect-producing treatments.

It's estimated that around 20 percent of men would be in such a high-risk category (for death or hospitalizations) and should consider not having a biopsy.

Study results appear in early online version of the journal Cancer.

The corresponding author is UC Irvine Health urologist Dr. Atreya Dash, who led the study of 104 patients. Co-authors include Drs. Sherrie Kaplan, John Billimek and Sheldon Greenfield of the Health Policy Research Institute at UC Irvine. Greenfield is an Institute of Medicine member and co-chaired an IOM study on comparative effectiveness research.

"Before prostate biopsy, providers should assess the number and severity of the patient's comorbid conditions to discuss whether proceeding with biopsy or therapy is likely to be beneficial," Dash said.


'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Page: 1

Related medicine news :

1. Comorbidities increase risk of mortality in COPD patients
2. Most Americans Should Eat Less Salt: Report
3. New Guidelines Say Doctors Should Screen All Adults for Risky Drinking
4. Docs Should Ask Heart Patients About Quality of Life
5. All hospitals should require drug, alcohol tests for physicians
6. Hospital surgical volume should be considered when judging value of procedures
7. The Vein Healthcare Center Explains Why Patients Should Wear Compression Before Varicose Vein Treatment, Plus Tips for Donning and Doffing Stockings
8. Many Parents Give Kids Cold Medicines When They Shouldnt, Survey Finds
9. Shoulder injuries in baseball pitchers could be prevented with 3-D motion detection system
10. Should kids sit less or move more? CHEO Research answers
11. 40 percent of parents give young kids cough/cold medicine that they shouldnt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t tell” applies perfectly ... in the company’s esteemed VISION House demonstration project series. Manifesting the concept of right-sized ... resources they need to live affordably and abundantly without unduly taxing the resources of ...
(Date:4/21/2017)... ... 21, 2017 , ... The VIA Agency , a ... Theravent, Inc. , the makers of a revolutionary new device clinically proven ... now working to expand distribution in anticipation of a national launch. VIA will ...
(Date:4/21/2017)... Arvada, CO (PRWEB) , ... April 21, 2017 ... ... health and performance system, has partnered with O2X , an active lifestyle ... are focused on improving the health of firefighters, police offers, first responders, military ...
(Date:4/21/2017)... ... April 21, 2017 , ... Alive for Wellness ... to overcome their mental health struggles. The Alive team uses advanced behavioral sciences ... approach in dealing with a mental health struggle is based on 10 modalities ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... anticipated Regional Primary Care Spring Symposium on April 1, 2017 in Santa Rosa. ... offering physicians and healthcare providers an opportunity to learn about cutting edge treatments, ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group leased ... is developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company ... life-threatening diseases that have been underserved by scientific ... therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... 18, 2017 Viverae ® , a leader ... integration of IBM ® Watson Campaign Automation, implementing ... communications for a personalized experience. Through digital engagement, the ... health in real time. The enhanced experience drives engagement ... members, wherever they are in their journey to health. ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and ... today announced the signing of a three-year exclusive ... will deploy a dedicated sales team to introduce ... U.S., primarily focused in 13 states in the ...
Breaking Medicine Technology: